These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27178605)

  • 41. Antidiabetic medication de-escalation following bariatric surgery.
    Vouri SM; Chen J; Sparkman J; Salles A; Micek ST
    J Diabetes; 2018 Sep; 10(9):768-770. PubMed ID: 29736976
    [No Abstract]   [Full Text] [Related]  

  • 42. Metabolic surgery provides remission of pancreatogenic diabetes in a non-obese patient.
    Chaux F; Franco M; Varela JE
    Surg Obes Relat Dis; 2016; 12(3):e25-e26. PubMed ID: 26686307
    [No Abstract]   [Full Text] [Related]  

  • 43. Balancing risks and benefits of bariatric surgery for type 2 diabetes.
    Peltonen M
    Lancet Diabetes Endocrinol; 2015 Jun; 3(6):394-395. PubMed ID: 25979363
    [No Abstract]   [Full Text] [Related]  

  • 44. Is type 2 diabetes reversible?
    Roach P
    Diabetes Forecast; 2016 Nov; 69(6):12. PubMed ID: 29693909
    [No Abstract]   [Full Text] [Related]  

  • 45. New therapies in the management of type 2 diabetes mellitus.
    Hardman TC; Dubrey SW
    Br J Hosp Med (Lond); 2013 Apr; 74(4):202-7. PubMed ID: 23571390
    [No Abstract]   [Full Text] [Related]  

  • 46. Alternative treatments for type 2 diabetes and associated metabolic diseases: medical therapy or endoscopic duodenal mucosal remodelling?
    van Baar ACG; Meiring S; Holleman F; Hopkins D; Mingrone G; Devière J; Nieuwdorp M; Bergman JJGHM
    Gut; 2021 Nov; 70(11):2196-2204. PubMed ID: 34497147
    [No Abstract]   [Full Text] [Related]  

  • 47. Changing the care pathway for Type 2 diabetes at the time of diagnosis: the role of the multidisciplinary team.
    Whyte MB; Munro N
    Diabet Med; 2019 May; 36(5):653-654. PubMed ID: 30378713
    [No Abstract]   [Full Text] [Related]  

  • 48. Letter to the Editor From Sarathi: "Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes".
    Sarathi V
    J Clin Endocrinol Metab; 2022 May; 107(6):e2644-e2645. PubMed ID: 35231117
    [No Abstract]   [Full Text] [Related]  

  • 49. [Not Available].
    Scheen AJ
    Rev Med Suisse; 2016 Aug; 12(527):1355-1356. PubMed ID: 28671787
    [No Abstract]   [Full Text] [Related]  

  • 50. [Type 2 diabetes].
    Mehnert H; Standl E
    Internist (Berl); 1998 Apr; 39(4):381-97. PubMed ID: 9599750
    [No Abstract]   [Full Text] [Related]  

  • 51. Histological pattern and gene expression profiling of thyroid tissue in subjects with obesity.
    Basolo A; Poma AM; Giannini R; Ceccarini G; Pelosini C; Fierabracci P; Castany MU; Bechi Genzano S; Ambrosini CE; Materazzi G; Chiovato L; Basolo F; Santini F; Torregrossa L
    J Endocrinol Invest; 2022 Feb; 45(2):413-423. PubMed ID: 34392500
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laparoscopic sleeve gastrectomy for morbid obesity and Klinefelter syndrome: clinical report on two patients, with long-term follow-up.
    Bianciardi E; Orsaria P; Niolu C; Siracusano A; Gentileschi P
    Eat Weight Disord; 2021 Jun; 26(5):1685-1690. PubMed ID: 32654003
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ophthalmologic evaluation of severely obese patients undergoing bariatric surgery: A pilot, monocentric, prospective, open-label study.
    Posarelli C; Salvetti G; Piaggi P; Guido F; Ceccarini G; Santini F; Figus M
    PLoS One; 2019; 14(5):e0216351. PubMed ID: 31095581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum IGF-binding protein 2 (IGFBP-2) concentrations change early after gastric bypass bariatric surgery revealing a possible marker of leptin sensitivity in obese subjects.
    Ceccarini G; Pelosini C; Ferrari F; Magno S; Vitti J; Salvetti G; Moretto C; Marioni A; Buccianti P; Piaggi P; Maffei M; Santini F
    Endocrine; 2019 Jul; 65(1):86-93. PubMed ID: 30945111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Remission of Type 2 Diabetes Mellitus in Patients After Different Types of Bariatric Surgery: A Population-Based Cohort Study in the United Kingdom.
    Yska JP; van Roon EN; de Boer A; Leufkens HG; Wilffert B; de Heide LJ; de Vries F; Lalmohamed A
    JAMA Surg; 2015 Dec; 150(12):1126-33. PubMed ID: 26422580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical considerations for the management of residual diabetes following bariatric surgery.
    Kashyap SR; Schauer P
    Diabetes Obes Metab; 2012 Sep; 14(9):773-79. PubMed ID: 22288474
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multidisciplinary treatment of a patient with type 2 diabetes and morbid obesity, or perhaps already a surgical diabetology.
    Szcześniak G; Jaworska J; Jaworski T; Dziemidok P
    Ann Agric Environ Med; 2012; 19(4):798-801. PubMed ID: 23311810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bariatric surgery versus medications in the treatment of type 2 diabetes.
    Fanin A; Benetti A; Ceriani V; Pontiroli AE
    Minerva Endocrinol; 2015 Dec; 40(4):297-306. PubMed ID: 26365477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Integrating medical and surgical therapies to optimize the outcomes of type 2 diabetes.
    Ceccarini G; Ciccarone AM; Santini F; Del Prato S
    Surg Obes Relat Dis; 2016 Jul; 12(6):1186-91. PubMed ID: 27178605
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.